| 2.56 Data as of May 17 |  -0.01 / -0.39%Today’s Change | 1.51 Today|||52-Week Range 4.00 | +33.33% Year-to-Date |
| Previous close | 2.57 |
| Today’s open | 2.60 |
| Day’s range | 2.54 - 2.60 |
| Volume | 307,302 |
| Average volume (3 months) | 475,351 |
| Market cap | $135.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -66.67% |
| Earnings growth (this year) | +16.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.72 |
| Today’s change | Today’s % change | |
|---|---|---|
| SLNCFSilence Therapeutics... | 0.00 | 0.00% |
| ONTYOncothyreon Inc | +0.02 | +1.02% |
| ENZEnzo Biochem Inc | +0.03 | +1.33% |
| BSTCBiospecifics Technol... | +0.17 | +1.08% |
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$14.5M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Scientific Officer John S. Yu, MD |
President, Chief Executive Officer & Director Andrew Gengos, MBA |
Corporate headquarters Woodland Hills, California |
.
